Scientists have shown how a lung cancer patient’s blood
sample could be used to monitor and predict their response to treatment –
paving the way for personalised medicine for the disease.
The recent study, published in the journal Nature Medicine,
also offers a method to test new therapies in the lab and to better understand
how tumours become resistant to drugs.